Is Paxlovid Any Better Than Placebo for Long COVID?

(MedPage Today) -- Nirmatrelvir-ritonavir (Paxlovid) wasn't any more effective at relieving long COVID symptoms than placebo, according to a large double-blind phase II trial.
At 90 days in RECOVER-VITAL, symptoms meaningfully improved among the...